Dosing any peptide correctly is a clinical decision, so it helps to understand how peptide therapy is supervised at Perfect B in Doral and where a specific peptide fits within a complete treatment plan
The peptide activates extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation in a dose-dependent manner, leading to nuclear translocation and activation of transcription factors including c-Fos, c-Jun, and early growth response-1 (Egr-1) that drive expression of genes involved in cell growth, migration, and angiogenesis
The clinical decision on protocol length and maintenance frequency is made at the APRN evaluation based on the individual patients response and goals
It is a common misconception that cellulite only affects people that areoverweight
That timeline assumes GHK-Cu is being used alongside a physical hair restoration treatment: PRP, exosomes, or microneedling with exosomes